OHSU in the news

GE Healthcare receives FDA approval for change in contraindications in prescribing Information for Optison

GE Healthcare October 05, 2021
In an announcement about the FDA removing hypersensitivity to blood and blood products as a contraindication for prescribing GE Healthcare’s Optison ultrasound enhancing agent for heart imaging, Jonathan Lindner, M.D., says ultrasound enhancing agents can improve diagnostic accuracy and echocardiogram interpretation, and that removing this contraindication “removes unnecessary hurdles to employing this valuable asset in cardiovascular imaging.”

Cost of Covid: Hospital stays longer, more costly for difficult treatment

Malheur Enterprise October 05, 2021
In a story on the cost of COVID hospitalizations, an OHSU spokesperson says: “We receive a large number of patients critically ill with COVID-19 and other conditions from around the state and provide the maximum level of care available to help them survive, if we can, which often requires longer lengths of stay and more resources.”

St. Charles health professionals vaccination rate near 90%

The Bend Bulletin October 05, 2021
“Hospitals throughout Oregon continue to manage high volumes of patients who require care for COVID-19 and other conditions,” Franny White, an OHSU spokesperson said. “To help maintain access to acute and emergency services, many hospitals statewide — including OHSU — have taken necessary steps such as reducing inpatient surgical cases to increase hospital capacity.”

A better name for booster shots

The Atlantic October 05, 2021
In a story exploring the meaning of a COVID “booster” shot and how getting one too soon or too often can be counterproductive, Mark Slifka, Ph.D., notes that after receiving several tetanus booster shots, “no matter how many more you give, you can’t get any higher antibody response."
See more stories